Phase II trial of ceftolozane/tazobactam in patients with nosocomial pneumonia.
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2012
At a glance
- Drugs Ceftolozane/tazobactam (Primary)
- Indications Gram-negative infections; Nosocomial pneumonia
- Focus Therapeutic Use
- 13 Sep 2012 Status changed from unconfirmed to recruiting.
- 15 Sep 2011 Status changed from planning to unconfirmed.
- 26 Jan 2010 New trial record